| __timestamp | Incyte Corporation | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 511495000 | 759285000 |
| Thursday, January 1, 2015 | 753751000 | 862944000 |
| Friday, January 1, 2016 | 1105719000 | 950751000 |
| Sunday, January 1, 2017 | 1536216000 | 879387000 |
| Monday, January 1, 2018 | 1881883000 | 661913000 |
| Tuesday, January 1, 2019 | 2158759000 | 669893000 |
| Wednesday, January 1, 2020 | 2666702000 | 644769000 |
| Friday, January 1, 2021 | 2986267000 | 548970000 |
| Saturday, January 1, 2022 | 3394635000 | 561347000 |
| Sunday, January 1, 2023 | 3695649000 | 572952000 |
| Monday, January 1, 2024 | 4241217000 | 629182000 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical industry, revenue generation is a key indicator of success. Over the past decade, Incyte Corporation has consistently outperformed Taro Pharmaceutical Industries Ltd. in terms of revenue. Starting in 2014, Incyte's revenue was approximately 33% lower than Taro's. However, by 2016, Incyte had surpassed Taro, marking a pivotal shift. By 2023, Incyte's revenue had grown to nearly 3.7 billion, more than six times Taro's 573 million. This remarkable growth trajectory highlights Incyte's strategic advancements and market positioning. Despite Taro's steady performance, Incyte's aggressive expansion and innovation have clearly paid off. The data for 2024 is incomplete, but the trend suggests Incyte's dominance is likely to continue. This analysis underscores the dynamic nature of the pharmaceutical sector and the importance of strategic growth.
Revenue Showdown: Novartis AG vs Taro Pharmaceutical Industries Ltd.
Amgen Inc. or Incyte Corporation: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: BeiGene, Ltd. vs Taro Pharmaceutical Industries Ltd.
Incyte Corporation and Walgreens Boots Alliance, Inc.: A Comprehensive Revenue Analysis
Incyte Corporation or MorphoSys AG: Who Leads in Yearly Revenue?
Incyte Corporation and Vericel Corporation: A Comprehensive Revenue Analysis
Research and Development Expenses Breakdown: Incyte Corporation vs Taro Pharmaceutical Industries Ltd.
Who Generates More Revenue? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Breaking Down Revenue Trends: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Revenue Insights: TG Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Performance Compared
Mesoblast Limited or Taro Pharmaceutical Industries Ltd.: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs MiMedx Group, Inc.